Skip to main content

About Us

About

Our Mission

Dedicated to providing quality data, reliable enrollment, and exceptional patient experience, driven by a culture of continuous improvement

Overview

Ideal Clinical Research has built a proven track record of success in high-enrollment clinical trials, particularly in vaccine development with renowned pharmaceutical partners.

In addition to vaccines, we actively conduct trials across a broad range of therapeutic areas, including:

  • Women’s Health
  • Internal Medicine
  • OB/GYN
  • Neurology
  • Psychiatry
  • Dermatology
  • Urology

Our commitment to data accuracy, protocol adherence, and regulatory excellence ensures the production of credible, high-quality data. To prevent dual enrollment and protect data validity, we utilize VCT (Verified Clinical Trials) biometric scanning — a state-of-the-art system designed to safeguard trial integrity.

Metrics & Startup Process

We leverage insights from hundreds of completed studies to deliver faster feasibility, smarter enrollment strategies, and seamless startup processes.

  • Feasibility questionnaires completed within 48 hours
  • Access to historical enrollment metrics improves forecasting and decision-making
  • Early identification of patient access and protocol alignment shortens timelines
  • Streamlined Contract & Budget Negotiations
  • Contracts and budgets are typically finalized within two weeks
  • IRB submission begins concurrently to eliminate unnecessary delays
  • Transparent and collaborative negotiation approach supports sponsor needs

Team

Our Investigators

Armando De Feria, MD

Principal Investigator | Internal Medicine

Harvey Glasser, MD

Principal Investigator | Women’s Health

Arthur Schatz, MD

Principal Investigator | Women’s Health

Harvey Samowitz, MD

Principal Investigator | Urology

Yoara Ramos-Mena, APRN, RN

Sub-Investigator

5
Therapeutic Areas
13
Years of Experience
400
Trials Conducted
32,000
Patient Database